scholarly journals Contribution to the validation of the anaphase-telophase test: aneugenic and clastogenic effects of cadmium sulfate, potassium dichromate and nickel chloride in Chinese hamster ovary cells

1999 ◽  
Vol 22 (4) ◽  
pp. 551-555 ◽  
Author(s):  
A.I. Seoane ◽  
F.N. Dulout

There is increasing evidence that aneuploidy during mitosis may be a factor in the etiology of somatic malignancy. The analysis of alterations in anaphase-telophase of mitosis is a useful test for evaluating the aneuploidogenic and clastogenic ability of chemicals. Several metals have been found to be carcinogenic to humans and animals. However, the underlying mechanisms remain unclear. In the present study the aneugenic and clastogenic abilities of cadmium sulfate, potassium dichromate and nickel chloride were analyzed using the anaphase-telophase test. Chinese hamster ovary (CHO) cells cultured for two cycles were treated with the desired compound for 8 h before cell harvesting. The frequency of cells with chromatin bridges, lagging chromosomes and lagging chromosomal fragments was scored. The mitotic index was determined by counting the number of mitotic cells per 1,000 cells on each coverslip and was expressed as a percentage of the number of mitotic plates. Statistical comparisons were done using the "G" method. Correlation and regression analyses were performed to evaluate variations of the mitotic index. Chromium and cadmium were clastogenic and aneugenic and increased the frequencies of the three types of aberrations scored; nickel had only aneugenic activity because it increased the frequency of lagging chromosomes. These results indicate that the anaphase-telophase test is sufficiently sensitive to detect dose-response relationships that can distinguish clastogenic and/or aneugenic activities and that the results obtained using the anaphase-telophase test were similar to those obtained by chromosome counting.

Pathology ◽  
1993 ◽  
Vol 25 (3) ◽  
pp. 268-276 ◽  
Author(s):  
Wanda B. Mackinnon ◽  
Marlen Dyne ◽  
Rebecca Hancock ◽  
Carolyn E. Mountford ◽  
Adrienne J. Grant ◽  
...  

Author(s):  
Shazid Md. Sharker ◽  
Md. Atiqur Rahman

Most of clinical approved protein-based drugs or under in clinical trial have a profound impact in the treatment of critical diseases. The mammalian eukaryotic cells culture approaches, particularly the CHO (Chinese Hamster Ovary) cells are mainly used in the biopharmaceutical industry for the mass-production of therapeutic protein. Recent advances in CHO cell bioprocessing to yield recombinant proteins and monoclonal antibodies have enabled the expression of quality protein. The developments of cell lines are possible to upgrade specific productivity. As a result, it holds an interesting area for academic as well as industrial researchers around the world. This review will concentrate on the recent progress of the mammalian CHO cells culture technology and the future scope of further development for the mass-production of protein therapeutics.


2021 ◽  
pp. e00649
Author(s):  
Valerie Schmieder ◽  
Neža Novak ◽  
Heena Dhiman ◽  
Ly Ngoc Nguyen ◽  
Evgenija Serafimova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document